Connection

Matthew Carpenter to Male

This is a "connection" page, showing publications Matthew Carpenter has written about Male.
Connection Strength

1.748
  1. A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation. Nicotine Tob Res. 2021 05 24; 23(6):983-991.
    View in: PubMed
    Score: 0.041
  2. The Impact of E-liquid Propylene Glycol and Vegetable Glycerin Ratio on Ratings of Subjective Effects, Reinforcement Value, and Use in Current Smokers. Nicotine Tob Res. 2020 04 21; 22(5):791-797.
    View in: PubMed
    Score: 0.038
  3. Electronic cigarette dependence and demand among pod mod users as a function of smoking status. Psychol Addict Behav. 2020 Nov; 34(7):804-810.
    View in: PubMed
    Score: 0.038
  4. The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):880-886.
    View in: PubMed
    Score: 0.038
  5. Impact of E-cigarette Sampling on Cigarette Dependence and Reinforcement Value. Nicotine Tob Res. 2020 02 06; 22(2):297-301.
    View in: PubMed
    Score: 0.038
  6. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial. Addiction. 2020 07; 115(7):1358-1367.
    View in: PubMed
    Score: 0.038
  7. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019 12 01; 173(12):1146-1153.
    View in: PubMed
    Score: 0.037
  8. Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands. Nicotine Tob Res. 2019 05 21; 21(6):784-791.
    View in: PubMed
    Score: 0.036
  9. Pilot randomized controlled trial of a Spanish-language Behavioral Activation mobile app (?Apt?vate!) for the treatment of depressive symptoms among united states Latinx adults with limited English proficiency. J Affect Disord. 2019 05 01; 250:210-217.
    View in: PubMed
    Score: 0.035
  10. Multi-method assessment of distress tolerance and smoking-related factors among adult daily smokers. Exp Clin Psychopharmacol. 2019 Apr; 27(2):136-145.
    View in: PubMed
    Score: 0.035
  11. Pilot Randomized Trial of a Self-Help Behavioral Activation Mobile App for Utilization in Primary Care. Behav Ther. 2019 07; 50(4):817-827.
    View in: PubMed
    Score: 0.035
  12. Longer duration of smoking abstinence is associated with waning cessation fatigue. Behav Res Ther. 2019 04; 115:12-18.
    View in: PubMed
    Score: 0.035
  13. Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers. J Consult Clin Psychol. 2018 Nov; 86(11):903-914.
    View in: PubMed
    Score: 0.035
  14. State Tobacco Policies as Predictors of Evidence-Based Cessation Method Usage: Results From a Large, Nationally Representative Dataset. Nicotine Tob Res. 2018 09 25; 20(11):1336-1343.
    View in: PubMed
    Score: 0.034
  15. One-Year Smoking Trajectories Among Established Adult Smokers With Low Baseline Motivation to Quit. Nicotine Tob Res. 2017 Dec 13; 20(1):50-57.
    View in: PubMed
    Score: 0.033
  16. Perceptions of Snus Among US Adult Smokers Given Free Product. Nicotine Tob Res. 2017 Dec 13; 20(1):22-29.
    View in: PubMed
    Score: 0.033
  17. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
    View in: PubMed
    Score: 0.032
  18. The differential impact of state tobacco control policies on cessation treatment utilization across established tobacco disparities groups. Prev Med. 2017 Dec; 105:319-325.
    View in: PubMed
    Score: 0.032
  19. Development and initial validation of a cessation fatigue scale. Drug Alcohol Depend. 2017 07 01; 176:102-108.
    View in: PubMed
    Score: 0.031
  20. Effectiveness of Switching Smoking-Cessation Medications Following Relapse. Am J Prev Med. 2017 Aug; 53(2):e63-e70.
    View in: PubMed
    Score: 0.031
  21. A pilot trial of In vivo NRT sampling to increase medication adherence in community corrections smokers. Addict Behav. 2017 04; 67:92-99.
    View in: PubMed
    Score: 0.030
  22. A Pilot Randomized Crossover Trial of Electronic Cigarette Sampling Among Smokers. Nicotine Tob Res. 2017 Feb; 19(2):176-182.
    View in: PubMed
    Score: 0.030
  23. A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus. Addict Behav. 2016 12; 63:82-8.
    View in: PubMed
    Score: 0.030
  24. Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers. Tob Control. 2017 03; 26(2):202-209.
    View in: PubMed
    Score: 0.029
  25. Prevalence of cigarette smoking and attempts to quit in a population-based cohort with spinal cord injury. Spinal Cord. 2015 Aug; 53(8):641-5.
    View in: PubMed
    Score: 0.027
  26. Impulsivity and cigarette craving among adolescent daily and occasional smokers. Addict Behav. 2015 Jun; 45:134-8.
    View in: PubMed
    Score: 0.027
  27. A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction. Psychol Addict Behav. 2015 Jun; 29(2):392-9.
    View in: PubMed
    Score: 0.026
  28. Impact of a brief telephone referral on quitline use, quit attempts and abstinence. Health Educ Res. 2015 Feb; 30(1):134-9.
    View in: PubMed
    Score: 0.026
  29. Affective motives for smoking among early stage smokers. Nicotine Tob Res. 2014 Oct; 16(10):1387-93.
    View in: PubMed
    Score: 0.026
  30. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014 Jul; 16(7):992-9.
    View in: PubMed
    Score: 0.025
  31. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014 Feb; 16(2):208-15.
    View in: PubMed
    Score: 0.024
  32. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013 Oct; 38(10):2541-6.
    View in: PubMed
    Score: 0.024
  33. Characteristics of cigarette smokers who want to quit now versus quit later. Addict Behav. 2013 Jun; 38(6):2257-60.
    View in: PubMed
    Score: 0.023
  34. The relationship between impulsivity, risk-taking propensity and nicotine dependence among older adolescent smokers. Addict Behav. 2013 Jan; 38(1):1431-4.
    View in: PubMed
    Score: 0.023
  35. Predictors of quit attempts and abstinence among smokers not currently interested in quitting. Nicotine Tob Res. 2012 Oct; 14(10):1197-204.
    View in: PubMed
    Score: 0.022
  36. Enhancing the effectiveness of smoking cessation interventions: a cancer prevention imperative. J Natl Cancer Inst. 2012 Feb 22; 104(4):260-2.
    View in: PubMed
    Score: 0.022
  37. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011 Nov 28; 171(21):1901-7.
    View in: PubMed
    Score: 0.021
  38. Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. J Natl Med Assoc. 2011 Sep-Oct; 103(9-10):885-94.
    View in: PubMed
    Score: 0.021
  39. 'Closet' quit attempts: prevalence, correlates and association with outcome. Addiction. 2011 Dec; 106(12):2214-20.
    View in: PubMed
    Score: 0.021
  40. Proactive recruitment in clinical trials: an idea whose time has come. Tob Control. 2011 Jul; 20(4):317.
    View in: PubMed
    Score: 0.021
  41. Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res. 2011 Aug; 13(8):646-52.
    View in: PubMed
    Score: 0.020
  42. Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. Addict Behav. 2011 Jan-Feb; 36(1-2):140-3.
    View in: PubMed
    Score: 0.020
  43. Assessment of nicotine dependence among adolescent and young adult smokers: a comparison of measures. Addict Behav. 2010 Nov; 35(11):977-82.
    View in: PubMed
    Score: 0.019
  44. A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit. Nicotine Tob Res. 2010 Feb; 12(2):136-43.
    View in: PubMed
    Score: 0.019
  45. Adolescent nondaily smokers: favorable views of tobacco yet receptive to cessation. Nicotine Tob Res. 2009 Apr; 11(4):348-55.
    View in: PubMed
    Score: 0.018
  46. Laboratory-based, cue-elicited craving and cue reactivity as predictors of naturally occurring smoking behavior. Addict Behav. 2009 Jun-Jul; 34(6-7):536-41.
    View in: PubMed
    Score: 0.018
  47. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use? Am J Addict. 2008 May-Jun; 17(3):195-8.
    View in: PubMed
    Score: 0.017
  48. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med. 2007 Feb; 33(1):22-8.
    View in: PubMed
    Score: 0.015
  49. Defining quit attempts: what difference does a day make? Addiction. 2005 Feb; 100(2):257-8.
    View in: PubMed
    Score: 0.013
  50. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol. 2004 Jun; 72(3):371-81.
    View in: PubMed
    Score: 0.013
  51. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res. 2003 Apr; 5(2):155-62.
    View in: PubMed
    Score: 0.012
  52. Daily adherence to nicotine replacement therapy in low-income smokers: The role of gender, negative mood, motivation, and self-efficacy. Addict Behav. 2023 03; 138:107543.
    View in: PubMed
    Score: 0.011
  53. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend. 2021 08 01; 225:108815.
    View in: PubMed
    Score: 0.010
  54. A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial. Nicotine Tob Res. 2021 05 24; 23(6):1064-1067.
    View in: PubMed
    Score: 0.010
  55. Intention to Quit Vaping Among United States Adolescents. JAMA Pediatr. 2021 01 01; 175(1):97-99.
    View in: PubMed
    Score: 0.010
  56. "I actually finally feel like the cigarettes aren't controlling me." - Interviews with participants smoking very low nicotine content cigarettes during a residential study. Drug Alcohol Depend. 2021 02 01; 219:108465.
    View in: PubMed
    Score: 0.010
  57. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382.
    View in: PubMed
    Score: 0.010
  58. Examining sex, adverse childhood experiences, and oxytocin on neuroendocrine reactivity in smokers. Psychoneuroendocrinology. 2020 10; 120:104752.
    View in: PubMed
    Score: 0.010
  59. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
    View in: PubMed
    Score: 0.009
  60. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555.
    View in: PubMed
    Score: 0.009
  61. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052.
    View in: PubMed
    Score: 0.009
  62. Delivery and implementation of an algorithm for smoking cessation treatment for people living with HIV and AIDS. AIDS Care. 2020 02; 32(2):223-229.
    View in: PubMed
    Score: 0.009
  63. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019 Jun; 27(3):265-275.
    View in: PubMed
    Score: 0.009
  64. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend. 1998 Dec 01; 53(1):11-5.
    View in: PubMed
    Score: 0.009
  65. Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570.
    View in: PubMed
    Score: 0.008
  66. Effect of a Brief Memory Updating Intervention on Smoking Behavior: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Mar 01; 74(3):214-223.
    View in: PubMed
    Score: 0.008
  67. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435.
    View in: PubMed
    Score: 0.008
  68. Milestone assessment of minimally invasive surgery in Pediatric Urology fellowship programs. J Pediatr Urol. 2017 Feb; 13(1):110.e1-110.e6.
    View in: PubMed
    Score: 0.007
  69. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope. 2017 01; 127(1):127-133.
    View in: PubMed
    Score: 0.007
  70. Adolescent Substance Use Following a Deadly U.S. Tornado Outbreak: A Population-Based Study of 2,000 Families. J Clin Child Adolesc Psychol. 2017 Sep-Oct; 46(5):732-745.
    View in: PubMed
    Score: 0.007
  71. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):990-995.
    View in: PubMed
    Score: 0.007
  72. Web Intervention for Adolescents Affected by Disaster: Population-Based Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2015 Sep; 54(9):709-17.
    View in: PubMed
    Score: 0.007
  73. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
    View in: PubMed
    Score: 0.007
  74. Gender differences in responses to cues presented in the natural environment of cigarette smokers. Nicotine Tob Res. 2015 Apr; 17(4):438-42.
    View in: PubMed
    Score: 0.007
  75. Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res. 2015 Apr; 17(4):463-72.
    View in: PubMed
    Score: 0.007
  76. Use of stop-smoking medications in the United States before and after the introduction of varenicline. Addiction. 2015 Feb; 110(2):346-55.
    View in: PubMed
    Score: 0.007
  77. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015 May; 17(5):607-11.
    View in: PubMed
    Score: 0.007
  78. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.006
  79. Risk behaviors related to cigarette smoking among persons with spinal cord injury. Nicotine Tob Res. 2014 Feb; 16(2):224-30.
    View in: PubMed
    Score: 0.006
  80. Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial. Nicotine Tob Res. 2014 Apr; 16(4):397-405.
    View in: PubMed
    Score: 0.006
  81. Trends in the use of premium and discount cigarette brands: findings from the ITC US Surveys (2002-2011). Tob Control. 2014 Mar; 23 Suppl 1:i48-53.
    View in: PubMed
    Score: 0.006
  82. Left-digit price effects on smoking cessation motivation. Tob Control. 2014 Nov; 23(6):501-6.
    View in: PubMed
    Score: 0.006
  83. Author response. Am J Prev Med. 2013 May; 44(5):e51-3.
    View in: PubMed
    Score: 0.006
  84. Harm reduction and cessation efforts and interest in cessation resources among survivors of smoking-related cancers. J Cancer Surviv. 2013 Mar; 7(1):44-54.
    View in: PubMed
    Score: 0.006
  85. Level of cigarette consumption and quit behavior in a population of low-intensity smokers--longitudinal results from the International Tobacco Control (ITC) survey in Mexico. Addict Behav. 2013 Apr; 38(4):1958-65.
    View in: PubMed
    Score: 0.006
  86. Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med. 2012 Dec; 43(6):590-600.
    View in: PubMed
    Score: 0.006
  87. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12.
    View in: PubMed
    Score: 0.006
  88. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict. 2012 May-Jun; 21(3):210-20.
    View in: PubMed
    Score: 0.006
  89. Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Res. 2011 Nov; 31(11):3891-5.
    View in: PubMed
    Score: 0.005
  90. Occasional smoking in college: who, what, when and why? Addict Behav. 2011 Dec; 36(12):1199-204.
    View in: PubMed
    Score: 0.005
  91. Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. Nicotine Tob Res. 2012 Feb; 14(2):234-9.
    View in: PubMed
    Score: 0.005
  92. Secondhand smoke exposure in young people and parental rules against smoking at home and in the car. Public Health Rep. 2011 Jul-Aug; 126(4):575-82.
    View in: PubMed
    Score: 0.005
  93. Dyadic efficacy for smoking cessation: preliminary assessment of a new instrument. Nicotine Tob Res. 2011 Mar; 13(3):194-201.
    View in: PubMed
    Score: 0.005
  94. Bupropion SR and contingency management for adolescent smoking cessation. J Subst Abuse Treat. 2011 Jan; 40(1):77-86.
    View in: PubMed
    Score: 0.005
  95. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
    View in: PubMed
    Score: 0.005
  96. Attention-deficit/hyperactivity disorder confounds nicotine withdrawal self-report in adolescent smokers. Am J Addict. 2010 Jul-Aug; 19(4):325-31.
    View in: PubMed
    Score: 0.005
  97. N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010 Mar-Apr; 19(2):187-9.
    View in: PubMed
    Score: 0.005
  98. Evidence for greater cue reactivity among low-dependent vs. high-dependent smokers. Addict Behav. 2010 Jul; 35(7):673-7.
    View in: PubMed
    Score: 0.005
  99. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
    View in: PubMed
    Score: 0.005
  100. The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May; 19(5):304-10.
    View in: PubMed
    Score: 0.004
  101. Barriers to genetic testing among persons at risk for alpha-1 antitrypsin deficiency. Genet Test. 2008 Dec; 12(4):501-5.
    View in: PubMed
    Score: 0.004
  102. Reactivity to nicotine cues over repeated cue reactivity sessions. Addict Behav. 2007 Dec; 32(12):2888-99.
    View in: PubMed
    Score: 0.004
  103. Internet-based intervention for mental health and substance use problems in disaster-affected populations: a pilot feasibility study. Behav Ther. 2006 Jun; 37(2):190-205.
    View in: PubMed
    Score: 0.004
  104. Genetic testing for alpha1-antitrypsin deficiency. Genet Med. 2004 Jul-Aug; 6(4):204-10.
    View in: PubMed
    Score: 0.003
  105. Physical activity and incident hypertension in black and white adults: the Atherosclerosis Risk in Communities Study. Prev Med. 1999 Mar; 28(3):304-12.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.